vs
Akebia Therapeutics, Inc.(AKBA)与Repay Holdings Corp(RPAY)财务数据对比。点击上方公司名可切换其他公司
Repay Holdings Corp的季度营收约是Akebia Therapeutics, Inc.的1.4倍($78.6M vs $57.6M),Akebia Therapeutics, Inc.同比增速更快(23.9% vs 0.4%),Akebia Therapeutics, Inc.自由现金流更多($31.1M vs $23.2M),过去两年Akebia Therapeutics, Inc.的营收复合增速更高(32.9% vs -1.3%)
Akebia Therapeutics是一家专注于肾病领域的生物制药企业,核心业务覆盖药物研发、临床试验及商业化推广全流程,主要开发针对慢性肾病相关贫血等适应症的创新疗法,面向全球市场,致力于满足肾病治疗领域未被满足的临床需求。
Repay Holdings Corp是一家聚焦北美市场的支付技术服务商,为零售、医疗、汽车服务、电商等领域的企业提供整合支付处理方案,涵盖银行卡收单、ACH转账、POS系统集成等数字化支付工具,助力客户简化交易流程、提升运营效率。
AKBA vs RPAY — 直观对比
营收规模更大
RPAY
是对方的1.4倍
$57.6M
营收增速更快
AKBA
高出23.5%
0.4%
自由现金流更多
AKBA
多$7.8M
$23.2M
两年增速更快
AKBA
近两年复合增速
-1.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $57.6M | $78.6M |
| 净利润 | — | $-140.1M |
| 毛利率 | 78.2% | 74.2% |
| 营业利润率 | -14.8% | -182.2% |
| 净利率 | — | -178.3% |
| 营收同比 | 23.9% | 0.4% |
| 净利润同比 | — | -3304.1% |
| 每股收益(稀释后) | $-0.05 | $-1.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
AKBA
RPAY
| Q4 25 | $57.6M | $78.6M | ||
| Q3 25 | $58.8M | $77.7M | ||
| Q2 25 | $62.5M | $75.6M | ||
| Q1 25 | $57.3M | $77.3M | ||
| Q4 24 | $46.5M | $78.3M | ||
| Q3 24 | $37.4M | $79.1M | ||
| Q2 24 | $43.6M | $74.9M | ||
| Q1 24 | $32.6M | $80.7M |
净利润
AKBA
RPAY
| Q4 25 | — | $-140.1M | ||
| Q3 25 | $540.0K | $-6.4M | ||
| Q2 25 | $247.0K | $-102.3M | ||
| Q1 25 | $6.1M | $-7.9M | ||
| Q4 24 | — | $-4.1M | ||
| Q3 24 | $-20.0M | $3.2M | ||
| Q2 24 | $-8.6M | $-4.1M | ||
| Q1 24 | $-18.0M | $-5.2M |
毛利率
AKBA
RPAY
| Q4 25 | 78.2% | 74.2% | ||
| Q3 25 | 84.0% | 74.4% | ||
| Q2 25 | 84.1% | 75.7% | ||
| Q1 25 | 86.7% | 75.9% | ||
| Q4 24 | 56.2% | 76.3% | ||
| Q3 24 | 62.2% | 77.8% | ||
| Q2 24 | 60.9% | 78.2% | ||
| Q1 24 | 64.4% | 76.2% |
营业利润率
AKBA
RPAY
| Q4 25 | -14.8% | -182.2% | ||
| Q3 25 | 7.6% | -3.9% | ||
| Q2 25 | 22.6% | -138.7% | ||
| Q1 25 | 23.6% | -4.7% | ||
| Q4 24 | -30.8% | -1.5% | ||
| Q3 24 | -33.4% | -0.9% | ||
| Q2 24 | -20.0% | -4.6% | ||
| Q1 24 | -45.8% | -3.1% |
净利率
AKBA
RPAY
| Q4 25 | — | -178.3% | ||
| Q3 25 | 0.9% | -8.3% | ||
| Q2 25 | 0.4% | -135.2% | ||
| Q1 25 | 10.7% | -10.3% | ||
| Q4 24 | — | -5.3% | ||
| Q3 24 | -53.5% | 4.1% | ||
| Q2 24 | -19.7% | -5.4% | ||
| Q1 24 | -55.2% | -6.5% |
每股收益(稀释后)
AKBA
RPAY
| Q4 25 | $-0.05 | $-1.68 | ||
| Q3 25 | $0.00 | $-0.08 | ||
| Q2 25 | $0.00 | $-1.15 | ||
| Q1 25 | $0.03 | $-0.09 | ||
| Q4 24 | $-0.10 | $-0.04 | ||
| Q3 24 | $-0.10 | $0.03 | ||
| Q2 24 | $-0.04 | $-0.04 | ||
| Q1 24 | $-0.09 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $184.8M | $115.7M |
| 总债务越低越好 | $48.3M | $280.1M |
| 股东权益账面价值 | $32.6M | $484.4M |
| 总资产 | $376.6M | $1.2B |
| 负债/权益比越低杠杆越低 | 1.48× | 0.58× |
8季度趋势,按日历期对齐
现金及短期投资
AKBA
RPAY
| Q4 25 | $184.8M | $115.7M | ||
| Q3 25 | $166.4M | $95.7M | ||
| Q2 25 | $137.3M | $162.6M | ||
| Q1 25 | $113.4M | $165.5M | ||
| Q4 24 | $51.9M | $189.5M | ||
| Q3 24 | $34.0M | $168.7M | ||
| Q2 24 | $39.5M | $147.1M | ||
| Q1 24 | $42.0M | $128.3M |
总债务
AKBA
RPAY
| Q4 25 | $48.3M | $280.1M | ||
| Q3 25 | $47.6M | $279.5M | ||
| Q2 25 | $47.1M | $279.0M | ||
| Q1 25 | $46.5M | $497.6M | ||
| Q4 24 | $38.7M | $496.8M | ||
| Q3 24 | $38.4M | $496.2M | ||
| Q2 24 | $38.0M | $435.6M | ||
| Q1 24 | $30.1M | $434.9M |
股东权益
AKBA
RPAY
| Q4 25 | $32.6M | $484.4M | ||
| Q3 25 | $41.6M | $616.9M | ||
| Q2 25 | $29.2M | $633.7M | ||
| Q1 25 | $24.6M | $755.7M | ||
| Q4 24 | $-49.2M | $761.3M | ||
| Q3 24 | $-50.4M | $754.7M | ||
| Q2 24 | $-33.8M | $815.4M | ||
| Q1 24 | $-27.3M | $813.8M |
总资产
AKBA
RPAY
| Q4 25 | $376.6M | $1.2B | ||
| Q3 25 | $364.2M | $1.3B | ||
| Q2 25 | $345.6M | $1.4B | ||
| Q1 25 | $310.2M | $1.5B | ||
| Q4 24 | $220.7M | $1.6B | ||
| Q3 24 | $207.1M | $1.6B | ||
| Q2 24 | $220.2M | $1.5B | ||
| Q1 24 | $225.5M | $1.5B |
负债/权益比
AKBA
RPAY
| Q4 25 | 1.48× | 0.58× | ||
| Q3 25 | 1.15× | 0.45× | ||
| Q2 25 | 1.61× | 0.44× | ||
| Q1 25 | 1.89× | 0.66× | ||
| Q4 24 | — | 0.65× | ||
| Q3 24 | — | 0.66× | ||
| Q2 24 | — | 0.53× | ||
| Q1 24 | — | 0.53× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $31.1M | $23.3M |
| 自由现金流经营现金流 - 资本支出 | $31.1M | $23.2M |
| 自由现金流率自由现金流/营收 | 53.9% | 29.6% |
| 资本支出强度资本支出/营收 | 0.1% | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $67.7M | $90.7M |
8季度趋势,按日历期对齐
经营现金流
AKBA
RPAY
| Q4 25 | $31.1M | $23.3M | ||
| Q3 25 | $28.1M | $32.2M | ||
| Q2 25 | $22.3M | $33.1M | ||
| Q1 25 | $-13.6M | $2.5M | ||
| Q4 24 | $-4.5M | $34.3M | ||
| Q3 24 | $-6.7M | $60.1M | ||
| Q2 24 | $-10.1M | $31.0M | ||
| Q1 24 | $-19.4M | $24.8M |
自由现金流
AKBA
RPAY
| Q4 25 | $31.1M | $23.2M | ||
| Q3 25 | $28.0M | $32.1M | ||
| Q2 25 | $22.2M | $33.0M | ||
| Q1 25 | $-13.6M | $2.4M | ||
| Q4 24 | $-4.5M | $34.0M | ||
| Q3 24 | $-6.7M | $59.8M | ||
| Q2 24 | $-10.1M | $30.5M | ||
| Q1 24 | — | $24.7M |
自由现金流率
AKBA
RPAY
| Q4 25 | 53.9% | 29.6% | ||
| Q3 25 | 47.7% | 41.3% | ||
| Q2 25 | 35.6% | 43.6% | ||
| Q1 25 | -23.7% | 3.0% | ||
| Q4 24 | -9.6% | 43.5% | ||
| Q3 24 | -17.9% | 75.6% | ||
| Q2 24 | -23.1% | 40.7% | ||
| Q1 24 | — | 30.6% |
资本支出强度
AKBA
RPAY
| Q4 25 | 0.1% | 0.1% | ||
| Q3 25 | 0.1% | 0.2% | ||
| Q2 25 | 0.2% | 0.1% | ||
| Q1 25 | 0.0% | 0.2% | ||
| Q4 24 | 0.0% | 0.3% | ||
| Q3 24 | 0.0% | 0.3% | ||
| Q2 24 | 0.1% | 0.6% | ||
| Q1 24 | 0.0% | 0.1% |
现金转化率
AKBA
RPAY
| Q4 25 | — | — | ||
| Q3 25 | 52.05× | — | ||
| Q2 25 | 90.47× | — | ||
| Q1 25 | -2.22× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 18.52× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AKBA
| Auryxia | $48.1M | 84% |
| Vafseo | $6.2M | 11% |
| License Collaboration And Other Revenue | $3.3M | 6% |
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |